✦ LIBER ✦
Qualification opinion of novel methodologies in the predementia stage of Alzheimer's disease: Cerebro-spinal-fluid related biomarkers for drugs affecting amyloid burden — Regulatory considerations by European Medicines Agency focusing in improving benefit/risk in regulatory trials
✍ Scribed by Maria Isaac; Spiros Vamvakas; Eric Abadie; Bertil Jonsson; Christine Gispen; Luca Pani
- Book ID
- 118437234
- Publisher
- Elsevier Science
- Year
- 2011
- Tongue
- English
- Weight
- 200 KB
- Volume
- 21
- Category
- Article
- ISSN
- 0924-977X
No coin nor oath required. For personal study only.